Search this site:
SORIN GROUP: UPDATE ON THE SHARE BUY-BACK PROGRAM
Milan, October 23, 2014 – In relation to the share buy-back program resolved by the ...
SORIN GROUP ANNOUNCES CE MARK APPROVAL AND FIRST IMPLANT OF MEMO 3D RECHORD™
A mitral valve annuloplasty ring with innovative chordal guiding system standardizes ...
SORIN GROUP PARTNERS WITH RESPICARDIA, INC., A DEVELOPER OF INNOVATIVE IMPLANTABLE THERAPIES DESIGNED TO IMPROVE RESPIRATORY AND CARDIOVASCULAR HEALTH
Investment will fund on-going clinical testing of the remedē® System for patients with ...
Cardiac Rhythm Management
Working at Sorin
Wake up your talent
Check for jobs